Growing community of inventors

Ostfildern, Germany

Colette Song

Average Co-Inventor Count = 6.06

ph-index = 13

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 903

Colette SongToni Weinschenk (213 patents)Colette SongJens Fritsche (213 patents)Colette SongHarpreet Singh (213 patents)Colette SongOliver Schoor (195 patents)Colette SongAndrea Mahr (107 patents)Colette SongDaniel Johannes Kowalewski (37 patents)Colette SongHeiko Schuster (33 patents)Colette SongSteffen Walter (22 patents)Colette SongAnita Wiebe (15 patents)Colette SongLinus Backert (11 patents)Colette SongClaudia Wagner (10 patents)Colette SongJulia Leibold (10 patents)Colette SongAnnika Sonntag (9 patents)Colette SongNorbert Hilf (8 patents)Colette SongSabrina Kuttruff-Coqui (8 patents)Colette SongFranziska Hoffgaard (4 patents)Colette SongSteffen Walter (4 patents)Colette SongAnita Weibe (1 patent)Colette SongColette Song (213 patents)Toni WeinschenkToni Weinschenk (606 patents)Jens FritscheJens Fritsche (567 patents)Harpreet SinghHarpreet Singh (505 patents)Oliver SchoorOliver Schoor (539 patents)Andrea MahrAndrea Mahr (348 patents)Daniel Johannes KowalewskiDaniel Johannes Kowalewski (159 patents)Heiko SchusterHeiko Schuster (152 patents)Steffen WalterSteffen Walter (79 patents)Anita WiebeAnita Wiebe (74 patents)Linus BackertLinus Backert (11 patents)Claudia WagnerClaudia Wagner (49 patents)Julia LeiboldJulia Leibold (26 patents)Annika SonntagAnnika Sonntag (22 patents)Norbert HilfNorbert Hilf (38 patents)Sabrina Kuttruff-CoquiSabrina Kuttruff-Coqui (9 patents)Franziska HoffgaardFranziska Hoffgaard (76 patents)Steffen WalterSteffen Walter (8 patents)Anita WeibeAnita Weibe (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Immatics Biotechnologies Gmbh (212 from 725 patents)


213 patents:

1. 12351616 - Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

2. 12297254 - Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

3. 12297245 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

4. 12281146 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

5. 12275768 - In immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

6. 12275776 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

7. 12275775 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

8. 12258382 - Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

9. 12247057 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

10. 12240877 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

11. 12240878 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

12. 12234276 - Uterine cancer treatments

13. 12226467 - Peptides and combination of peptides for use in immunotherapy against various cancers

14. 12221626 - Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

15. 12221468 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
10/4/2025
Loading…